NMC
EXAS

Nine Masts Capital’s Exact Sciences EXAS Stock Holding History

Nine Masts Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,300
Closed -$9K – 162
2019
Q2 		$9K Hold
10,300
– – ﹤0.01% 125
2019
Q1 		$73K Sell
10,300
-29,700
-74% -$2.53M 0.02% 107
2018
Q4 		$10K Buy
40,000
+39,600
+9,900% +$2.72M ﹤0.01% 163
2018
Q3 		$27K Buy
+400
New +$26.1K 0.01% 270
2018
Q2 		– Sell
-256
Closed -$132K – 314
2018
Q1 		$132K Sell
256
-50
-16% -$2.44K 0.02% 167
2017
Q4 		$70K Buy
+306
New +$16.3K 0.01% 160

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nine Masts Capital's EXAS Position: Q1 2026 in Review

Nine Masts Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 93,717 shares — an estimated $9.52M sold.

Nine Masts Capital first reported a position in EXAS in Q4 2017 and held it in 7 quarters. The position peaked at $9.52M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Nine Masts Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Nine Masts Capital sold 93,717 Exact Sciences shares in Q1 2026, an estimated $9.52M.
  • Nine Masts Capital first reported a position in Exact Sciences in Q4 2017 and held it in 7 quarters.
  • Nine Masts Capital's Exact Sciences position peaked at $9.52M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Nine Masts Capital's 13F filing for Q1 2026, filed 13 May 2026.